newsfilter
← Latest News
PR Newswire·

Orexo initiates exploratory feasibility studies of amorphOX® with two leading biopharmaceutical and vaccine companies

Orexo has successfully formulated Covid-19 spike protein in the proprietary drug delivery platform amorphOX®, showing excellent protein stabilityOrexo has initiated two exploratory feasibility studies applying